young
week
old
mix
sex
kitten
n
barrier
facil
known
neg
fcv
purchas
arriv
research
facil
sampl
collect
gentli
rub
steril
cotton
swab
oropharynx
level
molar
teeth
place
transport
cultur
aerob
bacteria
includ
b
bronchiseptica
mycoplasma
total
dna
rna
extract
second
pharyng
swab
evalu
dna
dna
gapdh
control
dna
polymeras
chain
reaction
pcr
well
rna
fcv
revers
transcriptas
pcr
assay
previous
vaccin
serum
collect
assay
fcv
antibodi
serum
kitten
test
chlamydophila
feli
kitten
random
util
random
number
gener
group
differ
area
facil
acclimat
day
kitten
shown
neg
antibodi
fcv
neg
fcv
nucleic
acid
pharyng
swab
neg
b
bronchiseptica
cultur
one
group
administ
singl
dose
intranas
fvrc
vaccin
accord
manufactur
day
group
vaccin
vaccin
facil
staff
member
use
barrier
precaut
avoid
kitten
modifi
live
vaccin
strain
fcv
protocol
approv
institut
anim
care
use
committe
research
facil
strain
b
bronchiseptica
grown
freez
solut
iowa
state
success
cultur
isol
ship
overnight
colorado
state
univers
broth
subcultur
provid
adequ
challeng
inoculum
b
bronchiseptica
isol
subcultur
onto
tsa
tryptic
soy
agar
sheep
blood
agar
plate
ensur
organ
pure
cultur
pure
cultur
confirm
isol
put
ml
tsb
tryptic
soy
broth
allow
grow
hour
ambient
air
day
investig
ml
administ
ml
inoculum
nari
kitten
quantit
cultur
isol
perform
morn
challeng
inocul
show
approxim
cfu
b
bronchiseptica
administ
kitten
clinic
score
perform
daili
day
inocul
b
bronchiseptica
previous
design
upper
respiratori
diseas
score
adapt
appli
cat
daili
train
individu
blind
treatment
group
tabl
use
system
total
point
possibl
per
day
accordingli
total
point
possibl
studi
period
clinic
observ
spent
minut
cat
room
time
day
appli
clinic
score
paramet
kitten
includ
whether
sneez
observ
kitten
observ
period
aural
temperatur
collect
estim
chang
bodi
temperatur
reduc
stress
kitten
induc
repeat
rectal
temperatur
aural
bodi
temperatur
accompani
lethargi
inappet
consid
evid
fever
day
b
bronchiseptica
challeng
pharyng
swab
collect
kitten
aerob
bacteri
cultur
mycoplasma
cultur
determin
whether
kitten
colon
b
bronchiseptica
observ
period
divid
day
post
inocul
day
post
inocul
day
cumul
result
also
compar
group
total
clinic
score
vaccin
cat
compar
control
cat
within
observ
period
use
proport
individu
cat
observ
sneez
within
observ
period
compar
group
fisher
exact
test
lastli
percentag
total
observ
point
sneez
record
calcul
group
within
observ
period
cat
per
group
observ
point
per
day
period
compar
fisher
exact
signific
defin
p
analys
vaccin
b
bronchiseptica
inocul
kitten
neg
antibodi
fcv
neg
nucleic
acid
fcv
pharyng
swab
neg
b
bronchiseptica
mycoplasma
spp
pharyng
swab
cultur
day
b
bronchiseptica
inocul
cat
posit
b
bronchiseptica
cat
neg
mycoplasma
spp
cultur
one
b
bronchiseptica
neg
kitten
vaccin
cat
group
sneez
record
observ
facil
staff
member
equilibr
period
first
day
vaccin
inocul
b
bronchiseptica
clinic
sign
diseas
gener
mild
group
cat
sneez
predomin
clinic
sign
diseas
group
cat
aural
temperatur
rare
detect
none
cat
ever
consid
inappet
letharg
suggest
fever
occur
addit
ocular
manifest
diseas
uncommon
total
ocular
score
group
compar
statist
none
cat
develop
clinic
sign
sever
enough
requir
support
care
antibiot
therapi
control
cat
day
median
cumul
clinic
score
cat
b
bronchiseptica
challeng
possibl
point
rang
vaccin
cat
day
median
cumul
clinic
score
cat
rang
day
result
challeng
analyz
median
cumul
clinic
score
control
cat
possibl
point
rang
vaccin
cat
day
median
cumul
clinic
score
cat
rang
control
cat
significantli
higher
cumul
clinic
score
per
cat
vaccin
cat
day
observ
period
p
fig
overal
control
cat
vaccin
cat
sneez
least
observ
period
day
inocul
b
bronchiseptica
p
differ
group
longer
appar
day
control
cat
vaccin
cat
sneez
least
percentag
observ
point
sneez
record
fig
significantli
greater
control
cat
vaccin
cat
day
p
day
p
studi
cat
administ
singl
dose
modifi
life
fcv
vaccin
intranas
lower
total
clinic
score
control
cat
first
day
challeng
mildli
pathogen
strain
b
bronchiseptica
result
unlik
affect
prior
immun
infect
spf
kitten
use
infect
b
bronchiseptica
mycoplasma
spp
fcv
rule
neg
test
inocul
find
support
hypothesi
intranas
vaccin
fcv
confer
challeng
infecti
agent
b
bronchiseptica
contain
vaccin
howev
measur
effect
lost
second
day
observ
challeng
suggest
protect
aforement
studi
efficaci
intranas
b
bronchiseptica
vaccin
rapid
protect
b
bronchiseptica
challeng
hour
vaccin
durat
immun
b
seem
plausibl
rapid
onset
protect
observ
nonspecif
immun
induc
process
intranas
vaccin
unintent
compon
vaccin
wherea
longer
term
protect
specif
acquir
immun
respons
b
bronchiseptica
base
current
studi
appear
vaccin
fcv
confer
durat
immun
organ
contain
within
vaccin
one
vaccin
cat
b
bronchiseptica
inocul
plausibl
cat
abl
clear
infect
possibl
assist
nonspecif
immun
confer
intranas
fcv
vaccin
howev
also
possibl
cultur
fals
neg
imperfect
sampl
cultur
techniqu
regardless
spf
cat
age
hous
handl
ident
administ
standard
dose
inoculum
like
cat
expos
colon
b
bronchiseptica
accordingli
data
cat
includ
analysi
mechan
nonspecif
immun
induc
intranas
vaccin
fulli
understood
unknown
whether
infecti
agent
within
vaccin
compon
cell
cultur
protein
one
theori
prior
vaccin
might
dampen
inflamm
caus
respiratori
infect
lessen
clinic
sign
diseas
howev
studi
demonstr
effect
b
pertussi
vaccin
influenza
mice
effect
lag
least
week
behind
vaccin
mechan
seem
unlik
explan
find
describ
stimul
innat
immun
system
intranas
vaccin
seem
like
explan
rapid
boost
innat
immun
occur
administr
chitin
microparticl
rodent
model
influenza
effect
attribut
activ
natur
killer
cell
well
regul
inflammatori
cytokin
seem
plausibl
one
compon
innat
immun
system
natur
killer
cell
recruit
unrel
intranas
treatment
could
compon
innat
immun
system
would
protect
effect
bacteri
infect
immun
respons
kitten
measur
present
studi
research
requir
determin
mediat
nonspecif
immun
regardless
mechan
stimul
nonspecif
immun
via
intranas
vaccin
would
sever
benefit
first
might
provid
protect
organ
vaccin
avail
routin
administ
mycoplasma
spp
cat
dog
canin
herpesviru
canin
respiratori
coronaviru
canin
influenza
viru
dog
second
nonspecif
immun
like
becom
activ
specif
immun
still
develop
therebi
confer
protect
quickli
vaccin
b
bronchiseptica
challeng
studi
day
intranas
vaccin
fcv
time
onset
nonspecif
immun
respons
investig
previou
work
demonstr
partial
immun
respons
earli
day
intranas
vaccin
cat
type
earli
protect
would
particular
valu
event
unforeseen
exposur
potenti
infecti
organ
exampl
emerg
board
shelter
environ
typic
stray
hold
period
day
might
financi
limit
number
vaccin
administ
present
studi
limit
rel
mild
clinic
sign
observ
vaccin
control
cat
cat
studi
describ
administ
larger
dose
strain
b
bronchiseptica
administ
previou
studi
cat
studi
much
milder
clinic
sign
strain
b
bronchiseptica
studi
approxim
year
possibl
storag
multipl
passag
freez
thaw
agent
render
less
addit
studi
describ
b
bronchiseptica
purpos
administ
cat
via
direct
inocul
rather
aerosol
avoid
need
sedat
attempt
minim
potenti
sever
system
ill
like
limit
inoculum
upper
respiratori
tissu
might
lessen
system
clinic
sign
diseas
like
fever
final
studi
studi
effect
induc
one
vaccin
administ
intranas
whether
similar
effect
would
recogn
administr
intranas
vaccin
parenter
vaccin
unknown
research
area
warrant
